Demonstrating broad geographical reach, K&L Gates’ international arbitration group represents a mix of sovereign and corporate clients in cross-border proceedings under ICSID, LCIA, ICC and ICDR rules, among others. The team’s ability to draw on its lawyers’ combination of judicial and arbitral experience also ensures that it is often selected to handle parallel litigation, including enforcement actions. Most notably, it is defending the Kingdom of Spain before US District Court in a case seeking to enforce a €291m ICSID Award. New York-based Matthew Weldon ‘is not afraid to get stuck in when the going gets tough.’
Testimonials
Collated independently by Legal 500 research team.
‘My speciality is international investment arbitration, and this is the only branch of international arbitration I am able to comment on. Within that area the firm is one of the leading ones. I have found the team to be highly efficient and well respected.’
‘I have worked with Matthew Weldon and I found him very knowledgeable and able.’
‘A strong arbitration practice, including a notable ability to oversee multi-jurisdictional matters and liaise with (e.g.) English barristers and solicitors in London-seated arbitrations under English law.’
‘Matthew Weldon is a stand-out performer. He is good at managing clients, carries a heavy caseload with apparent ease, and is not afraid to get stuck in when the going gets tough.’
Key clients
- Kingdom of Spain
- Government of Romania
- Republic of Italy Ministry of Economic Development
- Rolls Royce Power Solutions
- Petaquilla Minerals
- Cipla
- Chicago Bridge & Iron Company (CB&I) now McDermott
Work highlights
- Defending the Kingdom of Spain in US District Court against a petition made by NextEra Energy Global Holdings et al to enforce a €291m ICSID Award.
- Representing the Government of Romania in related matters, including three appeals, a US District Court action and an ICSID proceeding.
- Representing Cipla in a London-seated consolidated LCIA arbitration against a US-based licensee in relation to the blockbuster drug, Rifaximin.
Practice head
The lawyer(s) leading their teams.
Matthew Weldon